NCT04884243View on ClinicalTrials.gov

Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

September 5, 2021

Primary Completion Date

August 17, 2023

Study Completion Date

August 17, 2023

Conditions
Meibomian Gland Dysfunction
Interventions
DRUG

CBT-006

ophthalmic solution

Trial Locations (1)

92663

Eye Research Foundation, Newport Beach

Sponsors
All Listed Sponsors
lead

Cloudbreak Therapeutics, LLC

INDUSTRY